-
ViiV Healthcare Positive Action Programmes
We have been working with the HIV community since ViiV Healthcare was founded in 2009.
-
At ViiV Healthcare We Are All Connected To HIV
-
GSK's HIV business Viiv Healthcare acquires Bristol-Myers Squibb R&D; HIV assets
GSK announced that its global HIV business, ViiV Healthcare, has reached two separate agreements with Bristol-Myers Squibb, to acquire its late-stage HIV R&D; assets; and to acquire Bristol-Myers Squibb’s portfolio of preclinical and discovery stage HIV research assets.
GSK’s Chief Strategy Officer and ViiV Healthcare Chairman, David Redfern, explains why.
GSK - Do more, feel better, live longer.
-
CIPHER Grantees 2013 by ViiV Healthcare
CIPHER grantees 2013 by ViiV Healthcare
-
Siemens Healthcare Forms Partnerships With ViiV Healthcare, Tocagen
Siemens Healthcare Diagnostics (NYSE:SI) announces two new companion diagnostics partnerships with pharmaceutical companies ViiV Healthcare and Tocagen --mar...
-
Peter Gondwe visits ViiV Healthcare
Life Concern Executive Director Peter Gondwe visited ViiV Healthcare in March 2015. He presented on Life Concern's key achievements as a PACF grantee since 2011.
-
1° Campaña de Consejería y Detección de HIV
La agencia Brand Risers junto con el laboratorio GlaxoSmithKline y la Municipalidad de Chivilcoy llevaron a cabo la
1° Campaña de Consejería y Detección de HIV. Con solo una gota de sangre y en 20 minutos se obtienen los resultados del Test.
La acción se llevó a cabo en 4 etapas:
La 1er etapa fue la de concientización a los alumnos de 3er, 3to y 5to año de los colegios estatales y privado
-
Thai Red Cross AIDS Research Centre, amfAR and ViiV Healthcare at TemanTeman.org Press Con Indonesia
https://twitter.com/heytemanteman https://www.facebook.com/TEMANTEMAN.ORG http://www.temanteman.org Thai Red Cross AIDS Research Centre, amfAR and ViiV Healt...
-
2011 USCA ViiV Youth Scholars
ViiV Healthcare and the National Minority AIDS Council (NMAC) partnered to bring youth activists to the 2011 U.S. Conference on AIDS in Chicago.
-
HIV: la terapia diventa più “semplice”
E’ disponibile anche in Italia l’associazione precostituita per un approccio completo all’infezione con una singola compressa al giorno “Dolutegravir/Abacavir/Lamivudina.
Dolutegravir, l’inibitore delle proteasi frutto della ricerca ViiV Healthcare, è attualmente il solo medicinale per il trattamento di questa infezione che ha avuto il riconoscimento dall’Agenzia Italiana del Farmaco di farmaco
-
Side Effects And Talking With Your Healthcare Provider
Treatment side effects can sometimes be tough to deal with. See how some people spoke up to their healthcare providers about the side effects they were having, and found that other treatment options were available for them.
Please note: Licensing of Content is Non-Derivative - You may not alter, transform, or build upon this work. This resource is funded and developed by ViiV Healthcare. This res
-
Being Open With Your Healthcare Team
See others talk about the importance of speaking honestly with their healthcare team, and why that made a difference in how they feel about HIV and HIV treatment.
Please note: Licensing of Content is Non-Derivative - You may not alter, transform, or build upon this work. This resource is funded and developed by ViiV Healthcare. This resource is intended for US Residents only.
© 2015 ViiV Health
-
Press Conference - ViiV - International AIDS Conference
Press Conference - ViiV - International AIDS Conference, 24 July.
-
Blackberry beats expectations, 2016 forecasts, and a Bristol-Myers Squibb Deal
Blackberry (@NASDAQ $BBRY) beat all expectations and shares get a pop! Glaxo-Smith-Kline's (@NYSC $GSC) VIIV Healthcare unit will acquire HIV Drugs from rival Bristol-Myers Squibb (@NYSC $BMY) With 2016 two weeks away will you be using a fitness tracker or waiting for a medical wearable? Which small caps will benefit? Plus other small cap predictions for the new year.
-
Advancing the treatment of HIV/AIDS until there is a cure: Jim Demarest at TEDxElonUniversity
In the spirit of ideas worth spreading, TEDx is a program of local, self-organized events that bring people together to share a TED-like experience. At a TED...
-
Our Future - Dominique Limet
ViiV Healthcare CEO Dominique Limet describes some of the challenges facing the pharmaceutical industry, highlighting the importance of certain stakeholders and changing business models. In the midst of these changes, our focus on developing innovative products and inventing new treatment regimens that will truly benefit patients, remain the keys to our success.
HIV treatment has changed dramatic
-
What Makes Us Different - Dominique Limet
ViiV Healthcare CEO Dominique Limet explains how ViiV Healthcare thrives off the ethos of a small biotech and with the support of a large pharmaceutical company. This ‘hybrid model,’ combined with our singular focus on HIV, has helped to cultivate a distinct company culture underpinned by autonomy, responsibility and accountability. But there’s one key element that defines who we are:
“We have a
-
Fears About Starting Treatment
Hearing that you may need to start HIV meds is one thing. Actually starting them is quite another. Here's how some individuals have faced the challenges of going on HIV treatment.
Please note: Licensing of Content is Non-Derivative - You may not alter, transform, or build upon this work. This resource is funded and developed by ViiV Healthcare. This resource is intended for US Residents only.
©
-
Miss MIP présente le MIP - Emission 1
HF Prévention Santé Présente Le MIP !
Pour cette première émission nous recevons Miss MIP et le Virus VIH.
Le MIP est réalise avec le soutien de ViiV Healthcare
-
FirstWord Pharma Daily News Round-Up Video for December 18, 2015
The FirstWord Pharma Daily News Round-Up Video gives a recap of the latest pharmaceutical and biotechnology news. Stay abreast of the key industry news each day. Today's video highlights include ViiV Healthcare, Bristol-Myers Squibb, fostemsavir, Amgen, Imlygic, European Commission, AstraZeneca, Tagrisso, European Medicines Agency, Intercept Pharmaceuticals, obeticholic acid, FDA and durvalumab.
-
UTAS Pharmacy - make a career in healthcare
Meet Michael Grant, Country Manager of Viiv Healthcare. Michael has had a wide-ranging and successful career in healthcare as a pharmacist...
-
Personal Stories From People Living With HIV
Meet Stephanie, Dekota, Guy, Masonia, Devin, and Yuri. Listen as they share a little bit about their lives and their experiences living with HIV. To discover more information about HIV treatment and dealing with hang-ups, visit myhivhangup.com.
Please note: Licensing of Content is Non-Derivative - You may not alter, transform, or build upon this work. This resource is funded and developed by ViiV
-
Protest for access to Dolutegravir at ICASA 2015
Our friends of Y+ and ITPC-MENA held a protest at the ViiV - healthcare booth during ICASA 2015 in Harare, Zimbabwe. Dolutegravir is now available in all African countries but four. Check the full statment here: http://bit.ly/1XuxHKm
ViiV Healthcare Positive Action Programmes
We have been working with the HIV community since ViiV Healthcare was founded in 2009....
We have been working with the HIV community since ViiV Healthcare was founded in 2009.
wn.com/Viiv Healthcare Positive Action Programmes
We have been working with the HIV community since ViiV Healthcare was founded in 2009.
- published: 17 Jul 2015
- views: 58
GSK's HIV business Viiv Healthcare acquires Bristol-Myers Squibb R&D; HIV assets
GSK announced that its global HIV business, ViiV Healthcare, has reached two separate agreements with Bristol-Myers Squibb, to acquire its late-stage HIV R&D; as...
GSK announced that its global HIV business, ViiV Healthcare, has reached two separate agreements with Bristol-Myers Squibb, to acquire its late-stage HIV R&D; assets; and to acquire Bristol-Myers Squibb’s portfolio of preclinical and discovery stage HIV research assets.
GSK’s Chief Strategy Officer and ViiV Healthcare Chairman, David Redfern, explains why.
GSK - Do more, feel better, live longer.
Find out more on http://www.gsk.com
Follow @GSK on Twitter: http://twitter.com/GSK
Like GSK on Facebook: http://www.facebook.com/GSK
Follow GSK on LinkedIn: http://www.linkedin.com/company/glaxosmithkline
Subscribe to GSK on YouTube: http://www.youtube.com/subscription_center?add_user=gskvision
See more photos on GSK Flickr: http://www.flickr.com/photos/glaxosmithkline
Follow GSK on Google+: https://google.com/+GSK
wn.com/Gsk's Hiv Business Viiv Healthcare Acquires Bristol Myers Squibb R D Hiv Assets
GSK announced that its global HIV business, ViiV Healthcare, has reached two separate agreements with Bristol-Myers Squibb, to acquire its late-stage HIV R&D; assets; and to acquire Bristol-Myers Squibb’s portfolio of preclinical and discovery stage HIV research assets.
GSK’s Chief Strategy Officer and ViiV Healthcare Chairman, David Redfern, explains why.
GSK - Do more, feel better, live longer.
Find out more on http://www.gsk.com
Follow @GSK on Twitter: http://twitter.com/GSK
Like GSK on Facebook: http://www.facebook.com/GSK
Follow GSK on LinkedIn: http://www.linkedin.com/company/glaxosmithkline
Subscribe to GSK on YouTube: http://www.youtube.com/subscription_center?add_user=gskvision
See more photos on GSK Flickr: http://www.flickr.com/photos/glaxosmithkline
Follow GSK on Google+: https://google.com/+GSK
- published: 18 Dec 2015
- views: 197
CIPHER Grantees 2013 by ViiV Healthcare
CIPHER grantees 2013 by ViiV Healthcare...
CIPHER grantees 2013 by ViiV Healthcare
wn.com/Cipher Grantees 2013 By Viiv Healthcare
CIPHER grantees 2013 by ViiV Healthcare
- published: 15 Oct 2014
- views: 9
Siemens Healthcare Forms Partnerships With ViiV Healthcare, Tocagen
Siemens Healthcare Diagnostics (NYSE:SI) announces two new companion diagnostics partnerships with pharmaceutical companies ViiV Healthcare and Tocagen --mar......
Siemens Healthcare Diagnostics (NYSE:SI) announces two new companion diagnostics partnerships with pharmaceutical companies ViiV Healthcare and Tocagen --mar...
wn.com/Siemens Healthcare Forms Partnerships With Viiv Healthcare, Tocagen
Siemens Healthcare Diagnostics (NYSE:SI) announces two new companion diagnostics partnerships with pharmaceutical companies ViiV Healthcare and Tocagen --mar...
Peter Gondwe visits ViiV Healthcare
Life Concern Executive Director Peter Gondwe visited ViiV Healthcare in March 2015. He presented on Life Concern's key achievements as a PACF grantee since 2011...
Life Concern Executive Director Peter Gondwe visited ViiV Healthcare in March 2015. He presented on Life Concern's key achievements as a PACF grantee since 2011.
wn.com/Peter Gondwe Visits Viiv Healthcare
Life Concern Executive Director Peter Gondwe visited ViiV Healthcare in March 2015. He presented on Life Concern's key achievements as a PACF grantee since 2011.
- published: 17 Mar 2015
- views: 25
1° Campaña de Consejería y Detección de HIV
La agencia Brand Risers junto con el laboratorio GlaxoSmithKline y la Municipalidad de Chivilcoy llevaron a cabo la
1° Campaña de Consejería y Detección de HIV...
La agencia Brand Risers junto con el laboratorio GlaxoSmithKline y la Municipalidad de Chivilcoy llevaron a cabo la
1° Campaña de Consejería y Detección de HIV. Con solo una gota de sangre y en 20 minutos se obtienen los resultados del Test.
La acción se llevó a cabo en 4 etapas:
La 1er etapa fue la de concientización a los alumnos de 3er, 3to y 5to año de los colegios estatales y privados de la ciudad sobre enfermedades ITS. Las charlas estuvieron a cargo del infectólogo Daniel Curcio.
La 2da etapa se abocó a la comunicación a través de las principales radios de Chivilcoy, fuerte campaña de vía pública en la plaza central y puntos neurálgicos de la ciudad con el mensaje dirigido a ambos targets.
La 3era etapa fue del 14 al 18 de Noviembre (semana de detección) y se reforzó la comunicación con promotoras repartiendo la imagén de la campaña y de la ciudad en postales y sacando las dudas a los ciudadanos y reforzando el concepto de la campaña, se colocó señalética en la plaza central, windbanners en los boulevares de la ciudad y principales esquinas de la misma. Se diseñaron e imprimieron los formularios y papeles para administrar cada uno de los test a pedido de los infectólogos y por último se señalizó el hospital para que quienes se acerquen para hacerse el test no necesiten preguntar en que lugar se toma la muestra y de esta manera tener mayor confidencialidad y sentirse más cómodos.
La 4ta etapa es volcar todo el material cubierto en la campaña en la edición de un video en español e ingles con todo lo ocurrido durante el mes de la acción.
El objetivo era llegar a que 250 personas se lo realicen con la intención de demostrar el interés por este método y llegar a extrapolarlo a nivel Nacional. El objetivo fue cumplido y con creces ya que 470 personas se acercaron al Hospital Municipal para hacerse el test.
wn.com/1° Campaña De Consejería Y Detección De Hiv
La agencia Brand Risers junto con el laboratorio GlaxoSmithKline y la Municipalidad de Chivilcoy llevaron a cabo la
1° Campaña de Consejería y Detección de HIV. Con solo una gota de sangre y en 20 minutos se obtienen los resultados del Test.
La acción se llevó a cabo en 4 etapas:
La 1er etapa fue la de concientización a los alumnos de 3er, 3to y 5to año de los colegios estatales y privados de la ciudad sobre enfermedades ITS. Las charlas estuvieron a cargo del infectólogo Daniel Curcio.
La 2da etapa se abocó a la comunicación a través de las principales radios de Chivilcoy, fuerte campaña de vía pública en la plaza central y puntos neurálgicos de la ciudad con el mensaje dirigido a ambos targets.
La 3era etapa fue del 14 al 18 de Noviembre (semana de detección) y se reforzó la comunicación con promotoras repartiendo la imagén de la campaña y de la ciudad en postales y sacando las dudas a los ciudadanos y reforzando el concepto de la campaña, se colocó señalética en la plaza central, windbanners en los boulevares de la ciudad y principales esquinas de la misma. Se diseñaron e imprimieron los formularios y papeles para administrar cada uno de los test a pedido de los infectólogos y por último se señalizó el hospital para que quienes se acerquen para hacerse el test no necesiten preguntar en que lugar se toma la muestra y de esta manera tener mayor confidencialidad y sentirse más cómodos.
La 4ta etapa es volcar todo el material cubierto en la campaña en la edición de un video en español e ingles con todo lo ocurrido durante el mes de la acción.
El objetivo era llegar a que 250 personas se lo realicen con la intención de demostrar el interés por este método y llegar a extrapolarlo a nivel Nacional. El objetivo fue cumplido y con creces ya que 470 personas se acercaron al Hospital Municipal para hacerse el test.
- published: 21 Feb 2013
- views: 15
Thai Red Cross AIDS Research Centre, amfAR and ViiV Healthcare at TemanTeman.org Press Con Indonesia
https://twitter.com/heytemanteman https://www.facebook.com/TEMANTEMAN.ORG http://www.temanteman.org Thai Red Cross AIDS Research Centre, amfAR and ViiV Healt......
https://twitter.com/heytemanteman https://www.facebook.com/TEMANTEMAN.ORG http://www.temanteman.org Thai Red Cross AIDS Research Centre, amfAR and ViiV Healt...
wn.com/Thai Red Cross Aids Research Centre, Amfar And Viiv Healthcare At Temanteman.Org Press Con Indonesia
https://twitter.com/heytemanteman https://www.facebook.com/TEMANTEMAN.ORG http://www.temanteman.org Thai Red Cross AIDS Research Centre, amfAR and ViiV Healt...
2011 USCA ViiV Youth Scholars
ViiV Healthcare and the National Minority AIDS Council (NMAC) partnered to bring youth activists to the 2011 U.S. Conference on AIDS in Chicago....
ViiV Healthcare and the National Minority AIDS Council (NMAC) partnered to bring youth activists to the 2011 U.S. Conference on AIDS in Chicago.
wn.com/2011 Usca Viiv Youth Scholars
ViiV Healthcare and the National Minority AIDS Council (NMAC) partnered to bring youth activists to the 2011 U.S. Conference on AIDS in Chicago.
HIV: la terapia diventa più “semplice”
E’ disponibile anche in Italia l’associazione precostituita per un approccio completo all’infezione con una singola compressa al giorno “Dolutegravir/Abacavir/L...
E’ disponibile anche in Italia l’associazione precostituita per un approccio completo all’infezione con una singola compressa al giorno “Dolutegravir/Abacavir/Lamivudina.
Dolutegravir, l’inibitore delle proteasi frutto della ricerca ViiV Healthcare, è attualmente il solo medicinale per il trattamento di questa infezione che ha avuto il riconoscimento dall’Agenzia Italiana del Farmaco di farmaco innovativo, per i benefici aggiuntivi che offre rispetto alle opzioni già disponibili.
Il riconoscimento deriva dai risultati degli studi clinici del farmaco che hanno dimostrato un’efficacia virologica statisticamente superiore rispetto agli standard di cura attualmente in uso.
Purtroppo, a fronte del riconoscimento di AIFA per Dolutegravir, non esiste ancora un’uniformità di accesso in tutte le Regioni italiane al farmaco.
Interviste:
Adriano Lazzarin, Primario Divisione di Malattie Infettive IRCCS San Raffaele;
Maurizio Amato, Amministratore delegato ViiV Italia;
Rosaria Iardino, NPS Italia Onlus.
wn.com/Hiv La Terapia Diventa Più “Semplice”
E’ disponibile anche in Italia l’associazione precostituita per un approccio completo all’infezione con una singola compressa al giorno “Dolutegravir/Abacavir/Lamivudina.
Dolutegravir, l’inibitore delle proteasi frutto della ricerca ViiV Healthcare, è attualmente il solo medicinale per il trattamento di questa infezione che ha avuto il riconoscimento dall’Agenzia Italiana del Farmaco di farmaco innovativo, per i benefici aggiuntivi che offre rispetto alle opzioni già disponibili.
Il riconoscimento deriva dai risultati degli studi clinici del farmaco che hanno dimostrato un’efficacia virologica statisticamente superiore rispetto agli standard di cura attualmente in uso.
Purtroppo, a fronte del riconoscimento di AIFA per Dolutegravir, non esiste ancora un’uniformità di accesso in tutte le Regioni italiane al farmaco.
Interviste:
Adriano Lazzarin, Primario Divisione di Malattie Infettive IRCCS San Raffaele;
Maurizio Amato, Amministratore delegato ViiV Italia;
Rosaria Iardino, NPS Italia Onlus.
- published: 24 Nov 2015
- views: 53
Side Effects And Talking With Your Healthcare Provider
Treatment side effects can sometimes be tough to deal with. See how some people spoke up to their healthcare providers about the side effects they were having, ...
Treatment side effects can sometimes be tough to deal with. See how some people spoke up to their healthcare providers about the side effects they were having, and found that other treatment options were available for them.
Please note: Licensing of Content is Non-Derivative - You may not alter, transform, or build upon this work. This resource is funded and developed by ViiV Healthcare. This resource is intended for US Residents only.
© 2015 ViiV Healthcare. All rights reserved.
wn.com/Side Effects And Talking With Your Healthcare Provider
Treatment side effects can sometimes be tough to deal with. See how some people spoke up to their healthcare providers about the side effects they were having, and found that other treatment options were available for them.
Please note: Licensing of Content is Non-Derivative - You may not alter, transform, or build upon this work. This resource is funded and developed by ViiV Healthcare. This resource is intended for US Residents only.
© 2015 ViiV Healthcare. All rights reserved.
- published: 20 Aug 2015
- views: 32
Being Open With Your Healthcare Team
See others talk about the importance of speaking honestly with their healthcare team, and why that made a difference in how they feel about HIV and HIV treatmen...
See others talk about the importance of speaking honestly with their healthcare team, and why that made a difference in how they feel about HIV and HIV treatment.
Please note: Licensing of Content is Non-Derivative - You may not alter, transform, or build upon this work. This resource is funded and developed by ViiV Healthcare. This resource is intended for US Residents only.
© 2015 ViiV Healthcare. All rights reserved.
wn.com/Being Open With Your Healthcare Team
See others talk about the importance of speaking honestly with their healthcare team, and why that made a difference in how they feel about HIV and HIV treatment.
Please note: Licensing of Content is Non-Derivative - You may not alter, transform, or build upon this work. This resource is funded and developed by ViiV Healthcare. This resource is intended for US Residents only.
© 2015 ViiV Healthcare. All rights reserved.
- published: 20 Aug 2015
- views: 9
Press Conference - ViiV - International AIDS Conference
Press Conference - ViiV - International AIDS Conference, 24 July....
Press Conference - ViiV - International AIDS Conference, 24 July.
wn.com/Press Conference Viiv International Aids Conference
Press Conference - ViiV - International AIDS Conference, 24 July.
Blackberry beats expectations, 2016 forecasts, and a Bristol-Myers Squibb Deal
Blackberry (@NASDAQ $BBRY) beat all expectations and shares get a pop! Glaxo-Smith-Kline's (@NYSC $GSC) VIIV Healthcare unit will acquire HIV Drugs from rival B...
Blackberry (@NASDAQ $BBRY) beat all expectations and shares get a pop! Glaxo-Smith-Kline's (@NYSC $GSC) VIIV Healthcare unit will acquire HIV Drugs from rival Bristol-Myers Squibb (@NYSC $BMY) With 2016 two weeks away will you be using a fitness tracker or waiting for a medical wearable? Which small caps will benefit? Plus other small cap predictions for the new year.
wn.com/Blackberry Beats Expectations, 2016 Forecasts, And A Bristol Myers Squibb Deal
Blackberry (@NASDAQ $BBRY) beat all expectations and shares get a pop! Glaxo-Smith-Kline's (@NYSC $GSC) VIIV Healthcare unit will acquire HIV Drugs from rival Bristol-Myers Squibb (@NYSC $BMY) With 2016 two weeks away will you be using a fitness tracker or waiting for a medical wearable? Which small caps will benefit? Plus other small cap predictions for the new year.
- published: 19 Dec 2015
- views: 14
Advancing the treatment of HIV/AIDS until there is a cure: Jim Demarest at TEDxElonUniversity
In the spirit of ideas worth spreading, TEDx is a program of local, self-organized events that bring people together to share a TED-like experience. At a TED......
In the spirit of ideas worth spreading, TEDx is a program of local, self-organized events that bring people together to share a TED-like experience. At a TED...
wn.com/Advancing The Treatment Of Hiv Aids Until There Is A Cure Jim Demarest At Tedxelonuniversity
In the spirit of ideas worth spreading, TEDx is a program of local, self-organized events that bring people together to share a TED-like experience. At a TED...
- published: 01 Apr 2014
- views: 812
-
author: TEDx Talks
Our Future - Dominique Limet
ViiV Healthcare CEO Dominique Limet describes some of the challenges facing the pharmaceutical industry, highlighting the importance of certain stakeholders and...
ViiV Healthcare CEO Dominique Limet describes some of the challenges facing the pharmaceutical industry, highlighting the importance of certain stakeholders and changing business models. In the midst of these changes, our focus on developing innovative products and inventing new treatment regimens that will truly benefit patients, remain the keys to our success.
HIV treatment has changed dramatically over the years, but our work isn’t finished. Dominique maps out our ambitions for innovative HIV treatment, both today and in the future. In the next five to ten years, we are focused on making medicine even more effective and easier to take. We believe this will help to improve the lives of patients and open doors for further innovation.
“We want to become one of the key leaders in the field of HIV. We want to transform the way we treat HIV patients, because we care about HIV patients,” says Dominique. It is this passion for improving the lives of patients and dedication to innovative treatments that drives our company forward.
www.viivhealthcare.com
Follow ViiV Healthcare on Twitter: @ViiVHC
See the full feature here: http://kpmg.co.uk/creategraphics/2015/09_2015/CRT040098/index.html#4
This video was produced by KMPG LLP. ©2015 KPMG LLP. All Rights Reserved.
wn.com/Our Future Dominique Limet
ViiV Healthcare CEO Dominique Limet describes some of the challenges facing the pharmaceutical industry, highlighting the importance of certain stakeholders and changing business models. In the midst of these changes, our focus on developing innovative products and inventing new treatment regimens that will truly benefit patients, remain the keys to our success.
HIV treatment has changed dramatically over the years, but our work isn’t finished. Dominique maps out our ambitions for innovative HIV treatment, both today and in the future. In the next five to ten years, we are focused on making medicine even more effective and easier to take. We believe this will help to improve the lives of patients and open doors for further innovation.
“We want to become one of the key leaders in the field of HIV. We want to transform the way we treat HIV patients, because we care about HIV patients,” says Dominique. It is this passion for improving the lives of patients and dedication to innovative treatments that drives our company forward.
www.viivhealthcare.com
Follow ViiV Healthcare on Twitter: @ViiVHC
See the full feature here: http://kpmg.co.uk/creategraphics/2015/09_2015/CRT040098/index.html#4
This video was produced by KMPG LLP. ©2015 KPMG LLP. All Rights Reserved.
- published: 19 Oct 2015
- views: 21
What Makes Us Different - Dominique Limet
ViiV Healthcare CEO Dominique Limet explains how ViiV Healthcare thrives off the ethos of a small biotech and with the support of a large pharmaceutical company...
ViiV Healthcare CEO Dominique Limet explains how ViiV Healthcare thrives off the ethos of a small biotech and with the support of a large pharmaceutical company. This ‘hybrid model,’ combined with our singular focus on HIV, has helped to cultivate a distinct company culture underpinned by autonomy, responsibility and accountability. But there’s one key element that defines who we are:
“We have a great sense of purpose,” says Dominique, “We want to change how HIV patients are treated. We want to change their life.” This strong company culture and astute commercial acumen is our formula for success.
Dominique also talks about what we look for in people for our company:
“Having a challenger mindset with energy and passion which go with it, make people a bit different,” says Dominique. We seek people who are passionate and engaged, and are willing to challenge the status quo. By bringing in people who are ready to challenge how we work, ViiV Healthcare is better positioned to serve patients around the world.
www.viivhealthcare.com
Follow ViiV Healthcare on Twitter: @ViiVHC
See the full KPMG feature here: http://kpmg.co.uk/creategraphics/2015/09_2015/CRT040098/index.html#4
This video was produced by KMPG LLP. ©2015 KPMG LLP. All Rights Reserved.
wn.com/What Makes US Different Dominique Limet
ViiV Healthcare CEO Dominique Limet explains how ViiV Healthcare thrives off the ethos of a small biotech and with the support of a large pharmaceutical company. This ‘hybrid model,’ combined with our singular focus on HIV, has helped to cultivate a distinct company culture underpinned by autonomy, responsibility and accountability. But there’s one key element that defines who we are:
“We have a great sense of purpose,” says Dominique, “We want to change how HIV patients are treated. We want to change their life.” This strong company culture and astute commercial acumen is our formula for success.
Dominique also talks about what we look for in people for our company:
“Having a challenger mindset with energy and passion which go with it, make people a bit different,” says Dominique. We seek people who are passionate and engaged, and are willing to challenge the status quo. By bringing in people who are ready to challenge how we work, ViiV Healthcare is better positioned to serve patients around the world.
www.viivhealthcare.com
Follow ViiV Healthcare on Twitter: @ViiVHC
See the full KPMG feature here: http://kpmg.co.uk/creategraphics/2015/09_2015/CRT040098/index.html#4
This video was produced by KMPG LLP. ©2015 KPMG LLP. All Rights Reserved.
- published: 19 Oct 2015
- views: 23
Fears About Starting Treatment
Hearing that you may need to start HIV meds is one thing. Actually starting them is quite another. Here's how some individuals have faced the challenges of goin...
Hearing that you may need to start HIV meds is one thing. Actually starting them is quite another. Here's how some individuals have faced the challenges of going on HIV treatment.
Please note: Licensing of Content is Non-Derivative - You may not alter, transform, or build upon this work. This resource is funded and developed by ViiV Healthcare. This resource is intended for US Residents only.
© 2015 ViiV Healthcare. All rights reserved.
wn.com/Fears About Starting Treatment
Hearing that you may need to start HIV meds is one thing. Actually starting them is quite another. Here's how some individuals have faced the challenges of going on HIV treatment.
Please note: Licensing of Content is Non-Derivative - You may not alter, transform, or build upon this work. This resource is funded and developed by ViiV Healthcare. This resource is intended for US Residents only.
© 2015 ViiV Healthcare. All rights reserved.
- published: 20 Aug 2015
- views: 10
Miss MIP présente le MIP - Emission 1
HF Prévention Santé Présente Le MIP !
Pour cette première émission nous recevons Miss MIP et le Virus VIH.
Le MIP est réalise avec le soutien de ViiV Healthcar...
HF Prévention Santé Présente Le MIP !
Pour cette première émission nous recevons Miss MIP et le Virus VIH.
Le MIP est réalise avec le soutien de ViiV Healthcare
wn.com/Miss Mip Présente Le Mip Emission 1
HF Prévention Santé Présente Le MIP !
Pour cette première émission nous recevons Miss MIP et le Virus VIH.
Le MIP est réalise avec le soutien de ViiV Healthcare
- published: 06 Dec 2015
- views: 20
FirstWord Pharma Daily News Round-Up Video for December 18, 2015
The FirstWord Pharma Daily News Round-Up Video gives a recap of the latest pharmaceutical and biotechnology news. Stay abreast of the key industry news each day...
The FirstWord Pharma Daily News Round-Up Video gives a recap of the latest pharmaceutical and biotechnology news. Stay abreast of the key industry news each day. Today's video highlights include ViiV Healthcare, Bristol-Myers Squibb, fostemsavir, Amgen, Imlygic, European Commission, AstraZeneca, Tagrisso, European Medicines Agency, Intercept Pharmaceuticals, obeticholic acid, FDA and durvalumab.
wn.com/Firstword Pharma Daily News Round Up Video For December 18, 2015
The FirstWord Pharma Daily News Round-Up Video gives a recap of the latest pharmaceutical and biotechnology news. Stay abreast of the key industry news each day. Today's video highlights include ViiV Healthcare, Bristol-Myers Squibb, fostemsavir, Amgen, Imlygic, European Commission, AstraZeneca, Tagrisso, European Medicines Agency, Intercept Pharmaceuticals, obeticholic acid, FDA and durvalumab.
- published: 18 Dec 2015
- views: 10
UTAS Pharmacy - make a career in healthcare
Meet Michael Grant, Country Manager of Viiv Healthcare. Michael has had a wide-ranging and successful career in healthcare as a pharmacist......
Meet Michael Grant, Country Manager of Viiv Healthcare. Michael has had a wide-ranging and successful career in healthcare as a pharmacist...
wn.com/Utas Pharmacy Make A Career In Healthcare
Meet Michael Grant, Country Manager of Viiv Healthcare. Michael has had a wide-ranging and successful career in healthcare as a pharmacist...
Personal Stories From People Living With HIV
Meet Stephanie, Dekota, Guy, Masonia, Devin, and Yuri. Listen as they share a little bit about their lives and their experiences living with HIV. To discover mo...
Meet Stephanie, Dekota, Guy, Masonia, Devin, and Yuri. Listen as they share a little bit about their lives and their experiences living with HIV. To discover more information about HIV treatment and dealing with hang-ups, visit myhivhangup.com.
Please note: Licensing of Content is Non-Derivative - You may not alter, transform, or build upon this work. This resource is funded and developed by ViiV Healthcare. This resource is intended for US Residents only.
© 2015 ViiV Healthcare. All rights reserved.
wn.com/Personal Stories From People Living With Hiv
Meet Stephanie, Dekota, Guy, Masonia, Devin, and Yuri. Listen as they share a little bit about their lives and their experiences living with HIV. To discover more information about HIV treatment and dealing with hang-ups, visit myhivhangup.com.
Please note: Licensing of Content is Non-Derivative - You may not alter, transform, or build upon this work. This resource is funded and developed by ViiV Healthcare. This resource is intended for US Residents only.
© 2015 ViiV Healthcare. All rights reserved.
- published: 20 Aug 2015
- views: 25
Protest for access to Dolutegravir at ICASA 2015
Our friends of Y+ and ITPC-MENA held a protest at the ViiV - healthcare booth during ICASA 2015 in Harare, Zimbabwe. Dolutegravir is now available in all Africa...
Our friends of Y+ and ITPC-MENA held a protest at the ViiV - healthcare booth during ICASA 2015 in Harare, Zimbabwe. Dolutegravir is now available in all African countries but four. Check the full statment here: http://bit.ly/1XuxHKm
wn.com/Protest For Access To Dolutegravir At Icasa 2015
Our friends of Y+ and ITPC-MENA held a protest at the ViiV - healthcare booth during ICASA 2015 in Harare, Zimbabwe. Dolutegravir is now available in all African countries but four. Check the full statment here: http://bit.ly/1XuxHKm
- published: 01 Dec 2015
- views: 19
-
Positive Action for Children Fund Animation
-
FirstWord Pharma Daily News Round-Up Video for November 4, 2015
The FirstWord Pharma Daily News Round-Up Video gives a recap of the latest pharmaceutical and biotechnology news. Stay abreast of the key industry news each day. Today's video highlights include Allergan, ViiV Healthcare, cabotegravir, Johnson & Johnson, Edurant, Mylan, Perrigo, Lundbeck, Abilify Maintena, Brintellix and Northera.
-
MSM & Transgender Board Chairman - Main Objectives & First Proposals
Positive Action MSM Transgender Board Chairman, Juan Jacobo Hernandez Chavez talks about the importance of supporting those on the margins and reacts to the first round of successful applicants.
www.viivhealthcare.com
-
30.09.2015. 13. Басова А.М. Клинические проблемы в лечении ВИЧ-инфекции. Долутегравир.
Нерешенные клинические проблемы в лечении ВИЧ-инфекции. Долутегравир: от разработки до внедрения в клиническую практику.
Басова Анна Михайловна, к.м.н., региональный медицинский советник, компания VIIV Healthcare (г. Оренбург).
«СОЦИАЛЬНО-ЗНАЧИМЫЕ ИНФЕКЦИИ — ПРОБЛЕМЫ XXI ВЕКА: ДИАГНОСТИКА, ЛЕЧЕНИЕ, ПРОФИЛАКТИКА». Первый Уральский медицинский научно-практический Форум. Челябинск, ул. Труда, 179, от
-
Positive Action Europe 2014 Grantee Tour
A review of the impact Positive Action Europe has had on two of its grantees.
www.viivhealthcare.com
-
Reaching Out For Support
No matter where you are in your HIV journey, it's important to have support from the people around you. See where others got their support and how that helped them face the challenges of living with HIV.
Please note: Licensing of Content is Non-Derivative - You may not alter, transform, or build upon this work. This resource is funded and developed by ViiV Healthcare. This resource is intended fo
-
Making 90-90-90 a reality in Botswana
Dr Avalos and Dr Matshaba discuss importance of research and partnerships to continue progress towards delivering 90-90-90 goal in Botswana.
-
FirstWord Pharma Daily News Round-Up Video for July 3, 2015
The FirstWord Pharma Daily News Round-Up Video gives a recap of the latest pharmaceutical and biotechnology news. Stay abreast of the key industry news each day. Today's video highlights the FDA, Vertex Pharmaceuticals, Orkambi, GlaxoSmithKline, ViiV Healthcare, Tivicay, Gilead Sciences, Harvoni, Boehringer Ingelheim, Spiolto Respimat, Sanofi and Lantus.
-
ReShape roundtable on self-stigma
This roundtable on self-stigma was supported by International HIV Partnerships and ViiV Healthcare and coordinated by ReShape.
-
FirstWord Pharma Daily News Round-Up Video for May 6, 2015
The FirstWord Pharma Daily News Round-Up Video gives a recap of the latest pharmaceutical and biotechnology news. Stay abreast of the key industry news each day. Today's video highlights include GlaxoSmithKline, ViiV Healthcare, Alexion Pharmaceuticals, Synageva BioPharma, Kanuma, Lundbeck, Novo Nordisk, Mylan and Eli Lilly.
-
Every Footstep Counts Awards Ceremony
Every Footstep Counts Awards Ceremony at the International AIDS Conference in Melbourne, Australia.
Thanks to the IAC for the footage.
FirstWord Pharma Daily News Round-Up Video for November 4, 2015
The FirstWord Pharma Daily News Round-Up Video gives a recap of the latest pharmaceutical and biotechnology news. Stay abreast of the key industry news each day...
The FirstWord Pharma Daily News Round-Up Video gives a recap of the latest pharmaceutical and biotechnology news. Stay abreast of the key industry news each day. Today's video highlights include Allergan, ViiV Healthcare, cabotegravir, Johnson & Johnson, Edurant, Mylan, Perrigo, Lundbeck, Abilify Maintena, Brintellix and Northera.
wn.com/Firstword Pharma Daily News Round Up Video For November 4, 2015
The FirstWord Pharma Daily News Round-Up Video gives a recap of the latest pharmaceutical and biotechnology news. Stay abreast of the key industry news each day. Today's video highlights include Allergan, ViiV Healthcare, cabotegravir, Johnson & Johnson, Edurant, Mylan, Perrigo, Lundbeck, Abilify Maintena, Brintellix and Northera.
- published: 04 Nov 2015
- views: 31
MSM & Transgender Board Chairman - Main Objectives & First Proposals
Positive Action MSM Transgender Board Chairman, Juan Jacobo Hernandez Chavez talks about the importance of supporting those on the margins and reacts to the fir...
Positive Action MSM Transgender Board Chairman, Juan Jacobo Hernandez Chavez talks about the importance of supporting those on the margins and reacts to the first round of successful applicants.
www.viivhealthcare.com
wn.com/Msm Transgender Board Chairman Main Objectives First Proposals
Positive Action MSM Transgender Board Chairman, Juan Jacobo Hernandez Chavez talks about the importance of supporting those on the margins and reacts to the first round of successful applicants.
www.viivhealthcare.com
- published: 28 Oct 2015
- views: 27
30.09.2015. 13. Басова А.М. Клинические проблемы в лечении ВИЧ-инфекции. Долутегравир.
Нерешенные клинические проблемы в лечении ВИЧ-инфекции. Долутегравир: от разработки до внедрения в клиническую практику.
Басова Анна Михайловна, к.м.н., региона...
Нерешенные клинические проблемы в лечении ВИЧ-инфекции. Долутегравир: от разработки до внедрения в клиническую практику.
Басова Анна Михайловна, к.м.н., региональный медицинский советник, компания VIIV Healthcare (г. Оренбург).
«СОЦИАЛЬНО-ЗНАЧИМЫЕ ИНФЕКЦИИ — ПРОБЛЕМЫ XXI ВЕКА: ДИАГНОСТИКА, ЛЕЧЕНИЕ, ПРОФИЛАКТИКА». Первый Уральский медицинский научно-практический Форум. Челябинск, ул. Труда, 179, отель «Radisson Вlu». 30.09.2015 - 01.10.2015.
wn.com/30.09.2015. 13. Басова А.М. Клинические Проблемы В Лечении Вич Инфекции. Долутегравир.
Нерешенные клинические проблемы в лечении ВИЧ-инфекции. Долутегравир: от разработки до внедрения в клиническую практику.
Басова Анна Михайловна, к.м.н., региональный медицинский советник, компания VIIV Healthcare (г. Оренбург).
«СОЦИАЛЬНО-ЗНАЧИМЫЕ ИНФЕКЦИИ — ПРОБЛЕМЫ XXI ВЕКА: ДИАГНОСТИКА, ЛЕЧЕНИЕ, ПРОФИЛАКТИКА». Первый Уральский медицинский научно-практический Форум. Челябинск, ул. Труда, 179, отель «Radisson Вlu». 30.09.2015 - 01.10.2015.
- published: 26 Oct 2015
- views: 3
Positive Action Europe 2014 Grantee Tour
A review of the impact Positive Action Europe has had on two of its grantees.
www.viivhealthcare.com...
A review of the impact Positive Action Europe has had on two of its grantees.
www.viivhealthcare.com
wn.com/Positive Action Europe 2014 Grantee Tour
A review of the impact Positive Action Europe has had on two of its grantees.
www.viivhealthcare.com
- published: 20 Oct 2015
- views: 16
Reaching Out For Support
No matter where you are in your HIV journey, it's important to have support from the people around you. See where others got their support and how that helped t...
No matter where you are in your HIV journey, it's important to have support from the people around you. See where others got their support and how that helped them face the challenges of living with HIV.
Please note: Licensing of Content is Non-Derivative - You may not alter, transform, or build upon this work. This resource is funded and developed by ViiV Healthcare. This resource is intended for US Residents only.
© 2015 ViiV Healthcare. All rights reserved.
wn.com/Reaching Out For Support
No matter where you are in your HIV journey, it's important to have support from the people around you. See where others got their support and how that helped them face the challenges of living with HIV.
Please note: Licensing of Content is Non-Derivative - You may not alter, transform, or build upon this work. This resource is funded and developed by ViiV Healthcare. This resource is intended for US Residents only.
© 2015 ViiV Healthcare. All rights reserved.
- published: 20 Aug 2015
- views: 7
Making 90-90-90 a reality in Botswana
Dr Avalos and Dr Matshaba discuss importance of research and partnerships to continue progress towards delivering 90-90-90 goal in Botswana....
Dr Avalos and Dr Matshaba discuss importance of research and partnerships to continue progress towards delivering 90-90-90 goal in Botswana.
wn.com/Making 90 90 90 A Reality In Botswana
Dr Avalos and Dr Matshaba discuss importance of research and partnerships to continue progress towards delivering 90-90-90 goal in Botswana.
- published: 24 Jul 2015
- views: 28
FirstWord Pharma Daily News Round-Up Video for July 3, 2015
The FirstWord Pharma Daily News Round-Up Video gives a recap of the latest pharmaceutical and biotechnology news. Stay abreast of the key industry news each day...
The FirstWord Pharma Daily News Round-Up Video gives a recap of the latest pharmaceutical and biotechnology news. Stay abreast of the key industry news each day. Today's video highlights the FDA, Vertex Pharmaceuticals, Orkambi, GlaxoSmithKline, ViiV Healthcare, Tivicay, Gilead Sciences, Harvoni, Boehringer Ingelheim, Spiolto Respimat, Sanofi and Lantus.
wn.com/Firstword Pharma Daily News Round Up Video For July 3, 2015
The FirstWord Pharma Daily News Round-Up Video gives a recap of the latest pharmaceutical and biotechnology news. Stay abreast of the key industry news each day. Today's video highlights the FDA, Vertex Pharmaceuticals, Orkambi, GlaxoSmithKline, ViiV Healthcare, Tivicay, Gilead Sciences, Harvoni, Boehringer Ingelheim, Spiolto Respimat, Sanofi and Lantus.
- published: 05 Jul 2015
- views: 8
ReShape roundtable on self-stigma
This roundtable on self-stigma was supported by International HIV Partnerships and ViiV Healthcare and coordinated by ReShape....
This roundtable on self-stigma was supported by International HIV Partnerships and ViiV Healthcare and coordinated by ReShape.
wn.com/Reshape Roundtable On Self Stigma
This roundtable on self-stigma was supported by International HIV Partnerships and ViiV Healthcare and coordinated by ReShape.
- published: 27 Jun 2015
- views: 27
FirstWord Pharma Daily News Round-Up Video for May 6, 2015
The FirstWord Pharma Daily News Round-Up Video gives a recap of the latest pharmaceutical and biotechnology news. Stay abreast of the key industry news each day...
The FirstWord Pharma Daily News Round-Up Video gives a recap of the latest pharmaceutical and biotechnology news. Stay abreast of the key industry news each day. Today's video highlights include GlaxoSmithKline, ViiV Healthcare, Alexion Pharmaceuticals, Synageva BioPharma, Kanuma, Lundbeck, Novo Nordisk, Mylan and Eli Lilly.
wn.com/Firstword Pharma Daily News Round Up Video For May 6, 2015
The FirstWord Pharma Daily News Round-Up Video gives a recap of the latest pharmaceutical and biotechnology news. Stay abreast of the key industry news each day. Today's video highlights include GlaxoSmithKline, ViiV Healthcare, Alexion Pharmaceuticals, Synageva BioPharma, Kanuma, Lundbeck, Novo Nordisk, Mylan and Eli Lilly.
- published: 06 May 2015
- views: 17
Every Footstep Counts Awards Ceremony
Every Footstep Counts Awards Ceremony at the International AIDS Conference in Melbourne, Australia.
Thanks to the IAC for the footage....
Every Footstep Counts Awards Ceremony at the International AIDS Conference in Melbourne, Australia.
Thanks to the IAC for the footage.
wn.com/Every Footstep Counts Awards Ceremony
Every Footstep Counts Awards Ceremony at the International AIDS Conference in Melbourne, Australia.
Thanks to the IAC for the footage.
- published: 08 Aug 2014
- views: 22
-
Every Footstep Counts: PACF Filming Your Own Content Webinar
Find the storyboard template in the Files section of pacfonline.com Links used in storyboarding section: Water walk : vimeo.com/groups/9196/videos/86299224 v...
-
Maintaining emotional and psychological wellness
Support Program provides support services and health promotion for East and Southeast Asians living with HIV and their family/friends. This workshop took pla...
-
PACF Filming Your Own Content
PACF invited three experts - Leah Harris, Producer for GSK, Georgio Bosnic, Director of Motion Graphics at DJM Digital Solutions, and Heidi Lapensee from ViiV Healthcare - to host a webinar on how to create your video submission for our video competition 'Every Footstep Counts'. Every Footstep Counts is the opportunity for community groups like YOU that are working towards eMTCT of HIV to capture
-
Press Conference ViiV
7th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013), Kuala Lumpur, Malaysia - 30 June - 3 July 2013 ©International AIDS Society/Mondopop.
-
Innovative Business Models: Leveraging on partnerships Biopharma Asia Convention 2012
Strategy and investment, trends and solution for pharmaceutical industry- presentation and video content from our events, covering exploration, financing, ex...
-
23rd Dignity Conference 19: Culture, Religion, and HIV/Aids in Thailand, Patchanee Malikhao
The 23rd Annual Conference of the Human Dignity and Humiliation Studies network, titled 'Returning Dignity', took place at Chiang Mai University in Northern ...
-
Police threatening animal cruelty on Christmas eve - Shame Orange County, CA law enforcement !
Christmas eve 2011 to about January 6, 2012 Several months of the following year (April/May/June/August/Sept 2012) Sebastian (dog who passed away) Benjamin (...
-
Total Laboratory Automation - Michael Bissell, MD, Ph.D
In this University of Washington program, Dr. Michael Bissell of Ohio State University discusses James Reason's concept of "system opaqueness" to highly auto...
-
Analyzing the Challenges and Solutions for IHC Companion Diagnostics
The world of biomarker research has changed dramatically over the last 20 years with targeted therapy fundamentally changing drug development practices; there are not only new biomarkers but there are also complex biomarkers such as PD-L1. Due to this, the situation has moved to a matrix of therapeutics and companion diagnostics, rather than the direct 1:1 relationship of the past.
-
Synergy Session2 8 8
To date, the National Drug Abuse Clinical Trials Network Starting Treatment with Agonist Replacement Treatment Study (START) includes the largest database of patients (n=1269) entering opioid agonist treatment programs at community methadone centers around the United States (U.S.). Participants in the study were randomized to either Methadone (MET) treatment or Buprenorphine/Naloxone (BUP/Nx) trea
-
Molecular Biology Allergens Part 1 (COLA)
Brock Williams describes what makes a protein into an allergen.
Every Footstep Counts: PACF Filming Your Own Content Webinar
Find the storyboard template in the Files section of pacfonline.com Links used in storyboarding section: Water walk : vimeo.com/groups/9196/videos/86299224 v......
Find the storyboard template in the Files section of pacfonline.com Links used in storyboarding section: Water walk : vimeo.com/groups/9196/videos/86299224 v...
wn.com/Every Footstep Counts Pacf Filming Your Own Content Webinar
Find the storyboard template in the Files section of pacfonline.com Links used in storyboarding section: Water walk : vimeo.com/groups/9196/videos/86299224 v...
Maintaining emotional and psychological wellness
Support Program provides support services and health promotion for East and Southeast Asians living with HIV and their family/friends. This workshop took pla......
Support Program provides support services and health promotion for East and Southeast Asians living with HIV and their family/friends. This workshop took pla...
wn.com/Maintaining Emotional And Psychological Wellness
Support Program provides support services and health promotion for East and Southeast Asians living with HIV and their family/friends. This workshop took pla...
PACF Filming Your Own Content
PACF invited three experts - Leah Harris, Producer for GSK, Georgio Bosnic, Director of Motion Graphics at DJM Digital Solutions, and Heidi Lapensee from ViiV H...
PACF invited three experts - Leah Harris, Producer for GSK, Georgio Bosnic, Director of Motion Graphics at DJM Digital Solutions, and Heidi Lapensee from ViiV Healthcare - to host a webinar on how to create your video submission for our video competition 'Every Footstep Counts'. Every Footstep Counts is the opportunity for community groups like YOU that are working towards eMTCT of HIV to capture the impact of their project in a 3-4 minute film.
wn.com/Pacf Filming Your Own Content
PACF invited three experts - Leah Harris, Producer for GSK, Georgio Bosnic, Director of Motion Graphics at DJM Digital Solutions, and Heidi Lapensee from ViiV Healthcare - to host a webinar on how to create your video submission for our video competition 'Every Footstep Counts'. Every Footstep Counts is the opportunity for community groups like YOU that are working towards eMTCT of HIV to capture the impact of their project in a 3-4 minute film.
- published: 18 Feb 2014
- views: 3
Press Conference ViiV
7th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013), Kuala Lumpur, Malaysia - 30 June - 3 July 2013 ©International AIDS Society/Mondopop...
7th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013), Kuala Lumpur, Malaysia - 30 June - 3 July 2013 ©International AIDS Society/Mondopop.
wn.com/Press Conference Viiv
7th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013), Kuala Lumpur, Malaysia - 30 June - 3 July 2013 ©International AIDS Society/Mondopop.
Innovative Business Models: Leveraging on partnerships Biopharma Asia Convention 2012
Strategy and investment, trends and solution for pharmaceutical industry- presentation and video content from our events, covering exploration, financing, ex......
Strategy and investment, trends and solution for pharmaceutical industry- presentation and video content from our events, covering exploration, financing, ex...
wn.com/Innovative Business Models Leveraging On Partnerships Biopharma Asia Convention 2012
Strategy and investment, trends and solution for pharmaceutical industry- presentation and video content from our events, covering exploration, financing, ex...
23rd Dignity Conference 19: Culture, Religion, and HIV/Aids in Thailand, Patchanee Malikhao
The 23rd Annual Conference of the Human Dignity and Humiliation Studies network, titled 'Returning Dignity', took place at Chiang Mai University in Northern ......
The 23rd Annual Conference of the Human Dignity and Humiliation Studies network, titled 'Returning Dignity', took place at Chiang Mai University in Northern ...
wn.com/23Rd Dignity Conference 19 Culture, Religion, And Hiv Aids In Thailand, Patchanee Malikhao
The 23rd Annual Conference of the Human Dignity and Humiliation Studies network, titled 'Returning Dignity', took place at Chiang Mai University in Northern ...
Police threatening animal cruelty on Christmas eve - Shame Orange County, CA law enforcement !
Christmas eve 2011 to about January 6, 2012 Several months of the following year (April/May/June/August/Sept 2012) Sebastian (dog who passed away) Benjamin (......
Christmas eve 2011 to about January 6, 2012 Several months of the following year (April/May/June/August/Sept 2012) Sebastian (dog who passed away) Benjamin (...
wn.com/Police Threatening Animal Cruelty On Christmas Eve Shame Orange County, Ca Law Enforcement
Christmas eve 2011 to about January 6, 2012 Several months of the following year (April/May/June/August/Sept 2012) Sebastian (dog who passed away) Benjamin (...
- published: 05 Oct 2012
- views: 586
-
author: 18USC241
Total Laboratory Automation - Michael Bissell, MD, Ph.D
In this University of Washington program, Dr. Michael Bissell of Ohio State University discusses James Reason's concept of "system opaqueness" to highly auto......
In this University of Washington program, Dr. Michael Bissell of Ohio State University discusses James Reason's concept of "system opaqueness" to highly auto...
wn.com/Total Laboratory Automation Michael Bissell, Md, Ph.D
In this University of Washington program, Dr. Michael Bissell of Ohio State University discusses James Reason's concept of "system opaqueness" to highly auto...
- published: 15 Jul 2014
- views: 28
-
author: UWTV
Analyzing the Challenges and Solutions for IHC Companion Diagnostics
The world of biomarker research has changed dramatically over the last 20 years with targeted therapy fundamentally changing drug development practices; there a...
The world of biomarker research has changed dramatically over the last 20 years with targeted therapy fundamentally changing drug development practices; there are not only new biomarkers but there are also complex biomarkers such as PD-L1. Due to this, the situation has moved to a matrix of therapeutics and companion diagnostics, rather than the direct 1:1 relationship of the past.
wn.com/Analyzing The Challenges And Solutions For Ihc Companion Diagnostics
The world of biomarker research has changed dramatically over the last 20 years with targeted therapy fundamentally changing drug development practices; there are not only new biomarkers but there are also complex biomarkers such as PD-L1. Due to this, the situation has moved to a matrix of therapeutics and companion diagnostics, rather than the direct 1:1 relationship of the past.
- published: 07 Aug 2015
- views: 31
Synergy Session2 8 8
To date, the National Drug Abuse Clinical Trials Network Starting Treatment with Agonist Replacement Treatment Study (START) includes the largest database of pa...
To date, the National Drug Abuse Clinical Trials Network Starting Treatment with Agonist Replacement Treatment Study (START) includes the largest database of patients (n=1269) entering opioid agonist treatment programs at community methadone centers around the United States (U.S.). Participants in the study were randomized to either Methadone (MET) treatment or Buprenorphine/Naloxone (BUP/Nx) treatment, and closely monitored during induction as well as throughout active treatment and follow-up. Pharmacotherapy was provided for 24 weeks with taper or continuation possible through week 32. Primary outcomes showed low rates of liver injury and no differences in liver functions between MET and BUP/Nx groups. Secondary findings present a multitude of interesting and clinically relevant outcomes.
Part one focuses on the International Perspective with presentations by Adhi Wibowo Nurhidayat, MD, Mathew Hickman, PhD, and John Strang, MD. To complement the findings and dissemination strategies from the U.S. perspective, a panel of international collaborators will present findings from studies conducted abroad and implementation strategies that have been successful. Presentations will include outcomes from a collaborative project between NIDA and treatment providers in Indonesia, data from epidemiological studies showing the association between the length of MET treatment and mortality rates and dissemination and implementation strategies, and the use of incentive-based interventions in reducing drug use and associated consequences. The session will also describe the N-ALIVE (NALoxone InVEstigation) study--a large, prison-based, trial that assesses the number of lives that could be saved by providing Naloxone-on-release to adult prisoners with a history of heroin injection.
Part one focuses on the U.S. perspective.
wn.com/Synergy Session2 8 8
To date, the National Drug Abuse Clinical Trials Network Starting Treatment with Agonist Replacement Treatment Study (START) includes the largest database of patients (n=1269) entering opioid agonist treatment programs at community methadone centers around the United States (U.S.). Participants in the study were randomized to either Methadone (MET) treatment or Buprenorphine/Naloxone (BUP/Nx) treatment, and closely monitored during induction as well as throughout active treatment and follow-up. Pharmacotherapy was provided for 24 weeks with taper or continuation possible through week 32. Primary outcomes showed low rates of liver injury and no differences in liver functions between MET and BUP/Nx groups. Secondary findings present a multitude of interesting and clinically relevant outcomes.
Part one focuses on the International Perspective with presentations by Adhi Wibowo Nurhidayat, MD, Mathew Hickman, PhD, and John Strang, MD. To complement the findings and dissemination strategies from the U.S. perspective, a panel of international collaborators will present findings from studies conducted abroad and implementation strategies that have been successful. Presentations will include outcomes from a collaborative project between NIDA and treatment providers in Indonesia, data from epidemiological studies showing the association between the length of MET treatment and mortality rates and dissemination and implementation strategies, and the use of incentive-based interventions in reducing drug use and associated consequences. The session will also describe the N-ALIVE (NALoxone InVEstigation) study--a large, prison-based, trial that assesses the number of lives that could be saved by providing Naloxone-on-release to adult prisoners with a history of heroin injection.
Part one focuses on the U.S. perspective.
- published: 25 Feb 2015
- views: 1
Molecular Biology Allergens Part 1 (COLA)
Brock Williams describes what makes a protein into an allergen....
Brock Williams describes what makes a protein into an allergen.
wn.com/Molecular Biology Allergens Part 1 (Cola)
Brock Williams describes what makes a protein into an allergen.